Table 1.
Baseline patient characteristics.
| N=70 | ||
|---|---|---|
| Age, years, median (IQR) | 60 (52, 75) | |
| Sex, female, n (%) | 29 (41.4) | |
| Smoker, n (%) | 9 (12.9) | |
| Any comorbidity, n (%) | 57 (81.4) | |
| Obesity, n (%) | 7 (10.0) | |
| Hypertension, n (%) | 38 (54.3) | |
| Diabetes, n (%) | 17 (24.3) | |
| Chronic kidney disease, n (%) | 6 (8.6) | |
| Respiratory disease, n (%) | 13 (18.6) | |
| Malignancy, n (%) | 3 (4.3) | |
| Cirrhosis, n (%) | 2 (2.9) | |
| Atrial fibrillation, n (%) | 4 (5.7) | |
| Coronary artery disease, n (%) | 6 (8.6) | |
| Prior venous thromboembolism, n (%) | 2 (2.9) | |
| Coagulation and inflammatory parameters, median [IQR] | Normal values | |
| Platelet count, x109/L | 219 (170, 257) | 130-400 |
| White blood cells, x109/L | 6.2 (4.8, 8.5) | 4.8-10.8 |
| PT, seconds | 12.55 (12.15, 13.67) | 9-12 |
| aPTT, seconds | 30.9 (28.80, 32.70) | 0-38 |
| D-dimer, mg/dL | 1.09 (0.63, 2.33) | 0.00-0.50 |
| Fibrinogen, g/L | 5.54 (4.72, 6.98) | 180-400 |
| Antithrombin III, % | 99.00 (82.00, 106.50) | 75-125 |
| C reactive protein, mg/dL | 76.3 (52.3, 138.2) | 0.0-5.0 |
| Interleukin-6, pg/mL | 43.23 (26.30, 62.32) | 5.3-7.5 |
| Pro-calcitonin, ng/mL | 0.12 (0.06, 0.19) | <0.5 |
aPTT: activated partial thromboplastin time; PT: Prothrombin time.